Quantcast

Latest Hypolipidemic agent Stories

a4d077b71b40d3b2d9aa421f9fec088c1
2009-01-09 13:50:00

The US Food and Drug Administration on Thursday backed the cholesterol-lowering drug Vytorin following a review lasting almost one year.Agency officials said patients should not stop taking Vytorin or other drugs in its class, noting they observed no significant difference in carotid artery thickness between patients taking Merck, Schering-Plough's Vytorin and patients taking the drug Zocor.What's more, levels of LDL (bad) cholesterol decreased by 56 percent in the Vytorin group compared to...

632e27b8cf4dbf321723ce3a129f2a551
2008-12-09 11:55:38

Pregnant women or those hoping to start or extend a family should avoid using the cholesterol-lowering drugs statins, say scientists. Current clinical guidelines already recommend that women who are pregnant should stop taking statins but the advice is based on the knowledge that cholesterol is essential for normal fetal development. Indeed, a 2007 study examining the risk of congenital anomalies in children of pregnant women using statins suggested that the detrimental effects of the drugs...

2008-11-14 12:00:22

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- For the first time ever, a new study is providing direct evidence that cholesterol-lowering drugs called statins can prevent heart attacks, strokes and deaths among women. The study, released Sunday at the American Heart Association's conference in New Orleans, found that statins can cut heart attacks and strokes by about half -- even among people with normal cholesterol levels. About 40 percent of the study's participants were women, making...

2008-11-13 00:00:19

A Michigan State University researcher says she is studying whether a popular class of cholesterol-lowering drugs -- statins -- may cause muscle problems. Jill Slade, assistant professor of radiology and osteopathic manipulative medicine at Michigan State University, says there is accumulating evidence that the effect statins can have on skeletal muscle -- including muscle weakness, fatigue and deterioration -- is underestimated. "Statins work by preventing cholesterol from forming,"...

2008-11-10 18:00:05

WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- WomenHeart today urged women to talk with their doctors about heart disease risk factors in light of new research demonstrating the impact of statin therapy (cholesterol-lowering drugs) on cardiovascular events in women. The study, called JUPITER, found that statin therapy prevents heart attacks, strokes and deaths in women - even those with normal cholesterol levels and no signs of heart disease. "These new findings underscore the importance...

2008-10-29 12:00:07

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD). The newly published results of a major long-term study (J Neurol NeuroSurg Psychiatry Oct. 17, 2008) now provides powerful new evidence that taking statins substantially reduces the risk of AD. In this comprehensive study, researchers in The Netherlands found that older men and women who took statin drugs during the...

2008-10-20 12:00:10

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease. An important new study has found that ongoing statin drug use was associated with a 67% reduction in the risk of AD (Current Alzheimer Research 2008; 5: 416-421). The authors concluded that the "data suggest that statins produce a...

2008-09-30 12:00:15

The U.S. Food and Drug Administration says it has determined statins do not increase the incidence of amyotrophic lateral sclerosis, or Lou Gehrig's Disease. The FDA's review began in 2007 after the agency received a higher-than-expected number of reports of ALS developing in patients taking statins, cholesterol-lowering drugs. But officials said subsequent data from 41 long-term controlled clinical trials showed no increased incidence of the disease in patients treated with a statin...

2008-09-03 09:00:04

By MARIA CHENG By Maria Cheng The Associated Press MUNICH, Germany Results so far from three studies of the cholesterol-lowering drug Vytorin are not enough to prove or rule out a possible link to a higher risk of cancer, so the drug should be used with caution until more is known, editors of a leading medical journal urged Tuesday. The New England Journal of Medicine published results online from one study and an analysis of partial results from two others. They also were...

2008-09-03 06:00:06

By Alex Berenson When the U.S. Food and Drug Administration approved a new type of cholesterol-lowering medicine in 2002, it did so on the basis of a handful of clinical trials covering a total of 3,900 patients. None of the patients took the medicine for more than 12 weeks, and the trials offered no evidence that the treatment had reduced heart attacks or cardiovascular disease, the goal of any cholesterol drug. The lack of evidence has not stopped doctors from heavily prescribing that...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related